UCLA Health researchers have developed a novel blood test that measures cell-free DNA, offering a promising new method for ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

A heart transplant recipient safely carried a baby to term using noninvasive DNA monitoring—marking a new milestone in maternal and transplant care.

Salivary cell-free mitochondrial DNA may serve as a non-invasive, low-cost biomarker for early Alzheimer’s detection before cognitive decline begins.

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

The prenatal and newborn genetic testing market is expanding due to technological advancements in non-invasive methods, rising awareness of genetic disorders, and supportive policies. Key ...

With a closer look at genomic variation, scientists now have a faster, more precise way to uncover new links to disease EMBL ...